UK drug prices now lowest in Europe, says Health Dept
Prices of branded medicines in the UK have moved from being among the highest in Europe in 2004 to the lowest last year, the Department of Health has reported.
Read MoreAuthor: Lynne Taylor
HIV/AIDS drug patent pool “will save over $1 billion a year”
Agreement has been reached for a patent pool for AIDS medicines, which will start up in mid-2010 and is expected to generate savings of more than $1 billion a year.
Read MoreUS Senate votes down pharma imports plan
Proposals to allow US pharmacies and wholesalers to import prescription drugs from Australia, Canada, the European Union, Japan and New Zealand have been defeated in the Senate.
Read MoreAtrial fibrillation drug sales “to grow sevenfold-plus by 2018”
Sales of drugs to treat atrial fibrillation in seven major world markets are set to grow more than sevenfold to $6.1 billion by 2018 from $790 million last year, says a new report.
Read MoreExpensive health care not always best, global study shows
A new, 30-nation comparison of health care shows that all but three countries – the USA, Mexico and Turkey – currently provide their populations with universal or near-universal coverage for a core set of health services.
Read More- FDA approves new high dose Spinraza regimen for SMA
- Viridian reports positive results from elegrobart phase 3 trial
- Cure Parkinson’s convenes expert panel to assess £2 million combination therapy funding call
- Kygevvi approved in Europe as first treatment for TK2d
- Tozorakimab shows significant benefit in two major COPD trials
